Literature DB >> 1741396

The human 64-kDa polyadenylylation factor contains a ribonucleoprotein-type RNA binding domain and unusual auxiliary motifs.

Y Takagaki1, C C MacDonald, T Shenk, J L Manley.   

Abstract

Cleavage stimulation factor is one of the multiple factors required for 3'-end cleavage of mammalian pre-mRNAs. We have shown previously that this factor is composed of three subunits with estimated molecular masses of 77, 64, and 50 kDa and that the 64-kDa subunit can be UV-crosslinked to RNA in a polyadenylylation signal (AAUAAA)-dependent manner. We have now isolated cDNAs encoding the 64-kDa subunit of human cleavage stimulation factor. The 64-kDa subunit contains a ribonucleoprotein-type RNA binding domain in the N-terminal region and a repeat structure in the C-terminal region in which a pentapeptide sequence (consensus MEARA/G) is repeated 12 times and the formation of a long alpha-helix stabilized by salt bridges is predicted. An approximately 270-amino acid segment surrounding this repeat structure is highly enriched in proline and glycine residues (approximately 20% for each). When cloned 64-kDa subunit was expressed in Escherichia coli, an N-terminal fragment containing the RNA binding domain bound to RNAs in a polyadenylylation-signal-independent manner, suggesting that the RNA binding domain is directly involved in the binding of the 64-kDa subunit to pre-mRNAs.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1741396      PMCID: PMC48459          DOI: 10.1073/pnas.89.4.1403

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  49 in total

1.  An ordered pathway of assembly of components required for polyadenylation site recognition and processing.

Authors:  G M Gilmartin; J R Nevins
Journal:  Genes Dev       Date:  1989-12       Impact factor: 11.361

2.  A multisubunit factor, CstF, is required for polyadenylation of mammalian pre-mRNAs.

Authors:  Y Takagaki; J L Manley; C C MacDonald; J Wilusz; T Shenk
Journal:  Genes Dev       Date:  1990-12       Impact factor: 11.361

3.  Improved tools for biological sequence comparison.

Authors:  W R Pearson; D J Lipman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

Review 4.  Prediction of the secondary structure of proteins from their amino acid sequence.

Authors:  P Y Chou; G D Fasman
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1978

5.  Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis.

Authors:  D W Cleveland; S G Fischer; M W Kirschner; U K Laemmli
Journal:  J Biol Chem       Date:  1977-02-10       Impact factor: 5.157

6.  The sequence 5'-AAUAAA-3'forms parts of the recognition site for polyadenylation of late SV40 mRNAs.

Authors:  M Fitzgerald; T Shenk
Journal:  Cell       Date:  1981-04       Impact factor: 41.582

7.  Rna synthesis in isolated nuclei processing of adenovirus serotype 2 late messenger rna precursors.

Authors:  J L Manley; P A Sharp; M L Gefter
Journal:  J Mol Biol       Date:  1982-08-25       Impact factor: 5.469

8.  Multiple forms of poly(A) polymerases purified from HeLa cells function in specific mRNA 3'-end formation.

Authors:  L C Ryner; Y Takagaki; J L Manley
Journal:  Mol Cell Biol       Date:  1989-10       Impact factor: 4.272

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Analysis of RNA cleavage at the adenovirus-2 L3 polyadenylation site.

Authors:  C L Moore; H Skolnik-David; P A Sharp
Journal:  EMBO J       Date:  1986-08       Impact factor: 11.598

View more
  63 in total

1.  hnRNP F influences binding of a 64-kilodalton subunit of cleavage stimulation factor to mRNA precursors in mouse B cells.

Authors:  K L Veraldi; G K Arhin; K Martincic; L H Chung-Ganster; J Wilusz; C Milcarek
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

2.  Isolation and characterization of polyadenylation complexes assembled in vitro.

Authors:  K L Veraldi; G Edwalds-Gilbert; C C MacDonald; A M Wallace; C Milcarek
Journal:  RNA       Date:  2000-05       Impact factor: 4.942

3.  Complex protein interactions within the human polyadenylation machinery identify a novel component.

Authors:  Y Takagaki; J L Manley
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

4.  Two distinct forms of the 64,000 Mr protein of the cleavage stimulation factor are expressed in mouse male germ cells.

Authors:  A M Wallace; B Dass; S E Ravnik; V Tonk; N A Jenkins; D J Gilbert; N G Copeland; C C MacDonald
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

Review 5.  Formation of mRNA 3' ends in eukaryotes: mechanism, regulation, and interrelationships with other steps in mRNA synthesis.

Authors:  J Zhao; L Hyman; C Moore
Journal:  Microbiol Mol Biol Rev       Date:  1999-06       Impact factor: 11.056

6.  Recognition of GU-rich polyadenylation regulatory elements by human CstF-64 protein.

Authors:  José Manuel Pérez Cañadillas; Gabriele Varani
Journal:  EMBO J       Date:  2003-06-02       Impact factor: 11.598

7.  Separation of factors required for cleavage and polyadenylation of yeast pre-mRNA.

Authors:  J Chen; C Moore
Journal:  Mol Cell Biol       Date:  1992-08       Impact factor: 4.272

8.  Secondary structure as a functional feature in the downstream region of mammalian polyadenylation signals.

Authors:  Chunxiao Wu; James C Alwine
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

9.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1992-06-11       Impact factor: 16.971

10.  The upstream sequence element of the C2 complement poly(A) signal activates mRNA 3' end formation by two distinct mechanisms.

Authors:  A Moreira; Y Takagaki; S Brackenridge; M Wollerton; J L Manley; N J Proudfoot
Journal:  Genes Dev       Date:  1998-08-15       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.